Evidence map›Paper›PMID 24391773›Full record

ArticlePloS one2013

Low levels of peripheral CD161++CD8+ mucosal associated invariant T (MAIT) cells are found in HIV and HIV/TB co-infection.

Emily B Wong, Ngomu Akeem Akilimali, Pamla Govender, Zuri A Sullivan, Cormac Cosgrove, Mona Pillay, David M Lewinsohn, William R Bishai, Bruce D Walker, Thumbi Ndung'u and 2 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 98 citations in OpenAlex.

  1. Trial
  2. Gastrointestinal MAIT cells in chronic HIV-1 infection.Journal of immunology (Baltimore, Md. : 1950) · 2026
    Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

12 authors at 7 institutions in 4 countries.

Emily B WongKwaZulu-Natal Research Institute for Tuberculosis and HIV, Durban, South Africa ; Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts, United States of America.
Ngomu Akeem AkilimaliKwaZulu-Natal Research Institute for Tuberculosis and HIV, Durban, South Africa ; HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, South Africa.
Pamla GovenderKwaZulu-Natal Research Institute for Tuberculosis and HIV, Durban, South Africa ; HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, South Africa.
Zuri A SullivanKwaZulu-Natal Research Institute for Tuberculosis and HIV, Durban, South Africa ; Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
Cormac CosgrovePeter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
Mona PillayHIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, South Africa.
David M LewinsohnDivision of Pulmonary and Critical Care Medicine, Oregon Health & Science University, Portland, Oregon, United States of America ; Portland Veterans Administration Medical Center, Portland, Oregon, United States of America.
William R BishaiKwaZulu-Natal Research Institute for Tuberculosis and HIV, Durban, South Africa ; Division of Infectious Diseases, Johns Hopkins School of Medicine, Baltimore, Maryland, United States of America.
Bruce D WalkerHIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, South Africa ; The Ragon Institute of MGH, Massachusetts Institute of Technology, and Harvard, Harvard Medical School, Cambridge, Massachusetts, United States of America.
Thumbi Ndung'uKwaZulu-Natal Research Institute for Tuberculosis and HIV, Durban, South Africa ; HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, South Africa ; The Ragon Institute of MGH, Massachusetts Institute of Technology, and Harvard, Harvard Medical School, Cambridge, Massachusetts, United States of America ; Max Planck Institute for Infection Biology, Berlin, Germany.
Paul KlenermanPeter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
Victoria O KasprowiczKwaZulu-Natal Research Institute for Tuberculosis and HIV, Durban, South Africa ; HIV Pathogenesis Programme, University of KwaZulu-Natal, Durban, South Africa ; The Ragon Institute of MGH, Massachusetts Institute of Technology, and Harvard, Harvard Medical School, Cambridge, Massachusetts, United States of America.
University of KwaZulu-Natal · ZAMedawar Building for Pathogen Research · GBJohns Hopkins Medicine · USJohns Hopkins University · USMassachusetts General Hospital · USPortland VA Medical Center · USRagon Institute of MGH, MIT and Harvard · US

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI ROBERT A. PARKER · 2004 to 2026
$94.4M
Virology CoreU19AI082630 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI RAYMOND T CHUNG · 2009 to 2026
$48.1M
Human MAIT celis in airway mucosal immune responses to intracellular infectionsU01AI095776 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI LEWINSOHN, DAVID M. · 2011 to 2015
$8.9M
Multidisciplinary HIV Training ProgramT32AI007387 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI Daniel R. Kuritzkes · 1990 to 2026
$8.8M
Biomarkers and Signaling in TuberculosisR01AI097138 · NIAID · JOHNS HOPKINS UNIVERSITY · PI BISHAI, WILLIAM RAMSES · 2011 to 2014
$2.4M
NIAID NIH HHS 1U19AI082630-01NIAID NIH HHS AI 007387NIAID NIH HHS AI 097138NIAID NIH HHS P30 AI060354NIAID NIH HHS R01 AI097138NIAID NIH HHS T32 AI007387NIAID NIH HHS U01 AI095776NIAID NIH HHS U19 AI082630Wellcome Trust 091663Wellcome Trust WT019663MA
6 · The paper itself

Abstract

backgroundHigh expression of CD161 on CD8+ T cells is associated with a population of cells thought to play a role in mucosal immunity. We wished to investigate this subset in an HIV and Mycobacterium tuberculosis (MTB) endemic African setting.

methodsA flow cytometric approach was used to assess the frequency and phenotype of CD161++CD8+ T cells. 80 individuals were recruited for cross-sectional analysis: controls (n = 18), latent MTB infection (LTBI) only (n = 16), pulmonary tuberculosis (TB) only (n = 8), HIV only (n = 13), HIV and LTBI co-infection (n = 15) and HIV and TB co-infection (n = 10). The impact of acute HIV infection was assessed in 5 individuals recruited within 3 weeks of infection. The frequency of CD161++CD8+ T cells was assessed prior to and during antiretroviral therapy (ART) in 14 HIV-positive patients.

resultsCD161++CD8+ T cells expressed high levels of the HIV co-receptor CCR5, the tissue-homing marker CCR6, and the Mucosal-Associated Invariant T (MAIT) cell TCR Vα7.2. Acute and chronic HIV were associated with lower frequencies of CD161++CD8+ T cells, which did not correlate with CD4 count or HIV viral load. ART was not associated with an increase in CD161++CD8+ T cell frequency. There was a trend towards lower levels of CD161++CD8+ T cells in HIV-negative individuals with active and latent TB. In those co-infected with HIV and TB, CD161++CD8+ T cells were found at low levels similar to those seen in HIV mono-infection.

conclusionsThe frequencies and phenotype of CD161++CD8+ T cells in this South African cohort are comparable to those published in European and US cohorts. Low-levels of this population were associated with acute and chronic HIV infection. Lower levels of the tissue-trophic CD161++ CD8+ T cell population may contribute to weakened mucosal immune defense, making HIV-infected subjects more susceptible to pulmonary and gastrointestinal infections and detrimentally impacting on host defense against TB.

Indexed as

Immunity, MucosalAdolescentAdultAnti-HIV AgentsCase-Control StudiesCD8-Positive T-LymphocytesCohort StudiesCross-Sectional StudiesFemaleHIV InfectionsHumansLatent TuberculosisLymphocyte CountMaleMiddle AgedNK Cell Lectin-Like Receptor Subfamily BAnti-HIV AgentsKLRB1 protein, humanNK Cell Lectin-Like Receptor Subfamily B

Identifiers

PMID24391773
PMCPMC3877057
OpenAlexW2135397599

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.